Literature DB >> 120538

The effects of chlorpromazine and pentobarbital on behavior maintained by electric shock or point loss avoidance in humans.

M W Fischman, C R Schuster.   

Abstract

Human volunteer subjects were trained to press a lever to avoid or escape electric shock or loss of points which could be redeemed for money at the termination of the study. The effects of pentobarbital and chlorpromazine on avoidance and escape behavior were compared. Both aversive stimuli maintained behavior which was differentially sensitive to these two drugs. Chlorpromazine caused a decrease in avoidance responding at doses which had little effect on escape responding. Pentobarbital, in contrast, suppressed avoidance responding at doses which also had a suppressant effect on escape responding.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120538     DOI: 10.1007/bf00431981

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  EFFECTS OF DRUGS ON AVOIDANCE AND ESCAPE BEHAVIOR.

Authors:  L COOK; A C CATANIA
Journal:  Fed Proc       Date:  1964 Jul-Aug

2.  SOME OBSERVATIONS ON THE INTERACTION OF CHLORPROMAZINE AND FREE OPERANT AVOIDANCE BURSTS.

Authors:  F C CLARK; B J STEELE
Journal:  Psychopharmacologia       Date:  1963-05-15

3.  Continuous avoidance as a base-line for measuring behavioral effects of drugs.

Authors:  G A HEISE; E BOFF
Journal:  Psychopharmacologia       Date:  1962-10-05

4.  Behavioral effects of some psychopharmacological agents.

Authors:  L COOK; E WEIDLEY
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

5.  Effects of various drugs on escape and avoidance behavior.

Authors:  T VERHAVE; J E OWEN; O H SLATER
Journal:  Prog Neurobiol       Date:  1958       Impact factor: 11.685

6.  Time discrimination and behavioral interaction in a free operant situation.

Authors:  M SIDMAN
Journal:  J Comp Physiol Psychol       Date:  1956-10

7.  Technique for assessing the effects of drugs on timing behavior.

Authors:  M SIDMAN
Journal:  Science       Date:  1955-11-11       Impact factor: 47.728

8.  Effects of chlorpromazine on avoidance and escape responding in humans.

Authors:  M W Fischman; R C Smith; C R Schuster
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

9.  Effects of d-amphetamine and secobarbital on key press rates in normal humans.

Authors:  M Stitzer; E F Domino
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-02

10.  Facilitation and impairment of avoidance responding by phenobarbital sodium, chlordiazepoxide and diazepam--the role of performance base lines.

Authors:  G Bignami; L De Acetis; G L Gatti
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

View more
  5 in total

1.  Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics.

Authors:  James I Wasserman; Rebecca J Barry; Lisa Bradford; Nicholas J Delva; Richard J Beninger
Journal:  Psychopharmacology (Berl)       Date:  2012-01-12       Impact factor: 4.530

Review 2.  Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.

Authors:  Richard J Beninger; Tyson W Baker; Matthew M Florczynski; Tomek J Banasikowski
Journal:  Neurotox Res       Date:  2010-04-08       Impact factor: 3.911

3.  A single dose study of nabilone, a synthetic cannabinoid.

Authors:  R M Glass; E H Uhlenhuth; F W Hartel; C R Schuster; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 4.  Dopamine and incentive learning: a framework for considering antipsychotic medication effects.

Authors:  Richard J Beninger
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  The Role of Informative and Ambiguous Feedback in Avoidance Behavior: Empirical and Computational Findings.

Authors:  Ahmed A Moustafa; Jony Sheynin; Catherine E Myers
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.